Christopher Paul Simms is SVP, Chief Commercial Officer of IVERIC bio, Inc.. Currently has a direct ownership of 0 shares of ISEE, which is worth approximately $0. The most recent transaction as insider was on Jul 11, 2023, when has been sold 32,429 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Christopher Paul Simms Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 11 2023
SELL
Sale (or disposition) back to the issuer
-
32,429 Reduced 100.0%
0 Common Stock
Jan 03 2023
SELL
Open market or private sale
$47,502 $20.06 p/Share
2,368 Reduced 6.81%
32,429 Common Stock
Jan 02 2023
BUY
Exercise of conversion of derivative security
-
6,250 Added 15.23%
34,797 Common Stock
Aug 03 2022
SELL
Open market or private sale
$138,060 $11.25 p/Share
12,272 Reduced 30.06%
28,547 Common Stock
Aug 02 2022
BUY
Exercise of conversion of derivative security
-
33,750 Added 45.26%
40,819 Common Stock
Nov 18 2021
BUY
Open market or private purchase
$50,025 $16.3 p/Share
3,069 Added 30.27%
7,069 Common Stock
CPS

Christopher Paul Simms

SVP, Chief Commercial Officer
Parsippany, NJ

Track Institutional and Insider Activities on ISEE

Follow IVERIC bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ISEE shares.

Notify only if

Insider Trading

Get notified when an Iveric Bio, Inc. insider buys or sells ISEE shares.

Notify only if

News

Receive news related to IVERIC bio, Inc.

Track Activities on ISEE